Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
A phase 2 trial of Pixantrone in Breast cancer, run by Alliance for Clinical Trials in Oncology, completed.
Overview
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer is a phase 2 interventional study registered as NCT01086605 by Alliance for Clinical Trials in Oncology, with 46 participants recorded, started 2010-05 and reaching its primary completion in 2012-01. Interventions recorded: pixantrone dimaleate. Conditions recorded: Breast Cancer.
Linked to the drug Pixantrone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Shares Pixantrone and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- Trial[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Shares Breast cancer (all types) and the tag pipeline.
- TrialStudy on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.